David Witter

986 total citations
10 papers, 220 citations indexed

About

David Witter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, David Witter has authored 10 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in David Witter's work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). David Witter is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). David Witter collaborates with scholars based in United States, Netherlands and Taiwan. David Witter's co-authors include Jens Brodbeck, Matthew C. Childers, Anke Meyer‐Franke, Richard Hargreaves, Zofia Piotrowska, Casey C. McComas, Helena A. Yu, Danny Nguyen, Stephen B. Freedman and Maureen E. Balestra and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Organic Chemistry.

In The Last Decade

David Witter

10 papers receiving 211 citations

Peers

Countries citing papers authored by David Witter

Since Specialization

Citations

This map shows the geographic impact of David Witter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Witter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Witter more than expected).

Fields of papers citing papers by David Witter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Witter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Witter. The network helps show where David Witter may publish in the future.

Co-authorship network of co-authors of David Witter

This figure shows the co-authorship network connecting the top 25 collaborators of David Witter. A scholar is included among the top collaborators of David Witter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Witter. David Witter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Phase (Ph) 1/2a study of CLN-081 in patients (pts) with NSCLC with EGFR exon 20 insertion mutations (Ins20). 2022 ·Journal of Clinical Oncology ·Helena A. Yu, Daniel Shao-Weng Tan, Egbert F. Smit, Alexander I. Spira, Ross A. Soo, Danny Nguyen, Victor Lee, James Chih‐Hsin Yang, Vamsidhar Velcheti, John Wrangle, Mark A. Socinski, Marianna Koczywas, David Witter, (unknown), Leigh Zawel, John E. Janik, Zofia Piotrowska	25
2	Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues 2021 ·The Journal of Organic Chemistry ·David A. Candito, Yingchun Ye, (unknown), (unknown), David Witter, (unknown), Hongming Li, Josep Saurí, (unknown), Yu‐hong Lam, (unknown)	8
3	Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20). 2021 ·Journal of Clinical Oncology ·Zofia Piotrowska, Helena A. Yu, James Chih‐Hsin Yang, Marianna Koczywas, Egbert F. Smit, Daniel Shao-Weng Tan, Victor Lee, Ross A. Soo, John Wrangle, Alexander I. Spira, Vamsidhar Velcheti, Mark A. Socinski, (unknown), David Witter, Leigh Zawel, Jon M. Wigginton, (unknown), Danny Nguyen	28
4	1345P Preliminary safety and activity of CLN-081 in NSCLC with EGFR exon 20 insertion mutations (Ins20) 2020 ·Annals of Oncology ·Zofia Piotrowska, Danny Nguyen, Marianna Koczywas, Nishan Tchekmedyian, (unknown), David Witter, Angustias Page, Leigh Zawel, Helena A. Yu	9
5	Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Meredeth A. McGowan, (unknown), Matthew Christopher, Xavier Fradera, David Witter, Charles A. Lesburg, Chaomin Li, Joey L. Methot, John W. Lampe, (unknown), (unknown), (unknown), Sanjiv Shah, Alan Bass, Gottfried K. Schroeder, Dapeng Chen, Haoyu Zeng, Martin Augustin, Jason D. Katz	11
6	Estimation of Fraction Dissolved After Intratracheal Delivery of a Potent Janus Kinase Inhibitor, iJAK-001, with Low Solubility in Rat and Sheep: Impact of Preclinical PKPD on Inhaled Human Dose Projection 2019 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·(unknown), Hongshi Yu, Hyun‐Hee Lee, (unknown), David Witter, M Salmon, Peter W. Fan	4
7	P1.01-89 A Multicenter Phase 1/2a Trial of CLN-081 in NSCLC with EGFR Exon 20 Insertion Mutations 2019 ·Journal of Thoracic Oncology ·Zofia Piotrowska, David Planchard, (unknown), David Witter, Leigh Zawel, Helena A. Yu	2
8	Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors 2011 ·Journal of Biological Chemistry ·Jens Brodbeck, (unknown), Zhaoping Liu, Anke Meyer‐Franke, Maureen E. Balestra, (unknown), (unknown), Casey C. McComas, Fred Hess, David Witter, (unknown), Matthew C. Childers, Mark T. Goulet, Nigel J. Liverton, Richard Hargreaves, Stephen B. Freedman, Karl H. Weisgraber, Robert W. Mahley, Yadong Huang	84
9	Glucokinase-activating ureas 2005 ·Bioorganic & Medicinal Chemistry Letters ·Arlindo L. Castelhano, Hanqing Dong, Matthew C. T. Fyfe, (unknown), (unknown), (unknown), Masao Nawano, Rikiya Ohashi, Martin J. Procter, Qiu Li, Chrystelle M. Rasamison, (unknown), (unknown), Kiichiro Ueta, Geoffrey M. Williams, David Witter, Kōsuke Yasuda	35
10	Sugarcane exposure and the risk of lung cancer and mesothelioma 1992 ·Environmental Research ·Stuart M. Brooks, Heather Stockwell, (unknown), Adam W. Armstrong, David Witter	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact